Tolerance-Is it worth it?

Erik B Finger, Terry B. Strom, Arthur J Matas

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We are entering an exciting time in the study of immunologic tolerance. Several cellular and molecular strategies have been developed that show promise in nonhuman transplant models and these approaches are just now appearing in clinical trials. Tolerance strategies that prevent immune rejection and obviate the need for immunosuppressive medications (with inherent risk of cancer, infection, and organ toxicity) would improve both graft and patient survival. Each tolerance protocol brings its ownset of associated risks. As the results of these trials become available,we must continue to evaluate their successes and failures. The balance of these outcomes will help us answer the question: "Tolerance-Is it worth it?"

Original languageEnglish (US)
JournalCold Spring Harbor perspectives in medicine
Volume4
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Graft Survival
Immunosuppressive Agents
Clinical Trials
Transplants
Infection
Grafts
Toxicity
Neoplasms

Cite this

Tolerance-Is it worth it? / Finger, Erik B; Strom, Terry B.; Matas, Arthur J.

In: Cold Spring Harbor perspectives in medicine, Vol. 4, No. 2, 01.01.2014.

Research output: Contribution to journalArticle

@article{d58f9fe5a14c4746ac86a6c957eac81c,
title = "Tolerance-Is it worth it?",
abstract = "We are entering an exciting time in the study of immunologic tolerance. Several cellular and molecular strategies have been developed that show promise in nonhuman transplant models and these approaches are just now appearing in clinical trials. Tolerance strategies that prevent immune rejection and obviate the need for immunosuppressive medications (with inherent risk of cancer, infection, and organ toxicity) would improve both graft and patient survival. Each tolerance protocol brings its ownset of associated risks. As the results of these trials become available,we must continue to evaluate their successes and failures. The balance of these outcomes will help us answer the question: {"}Tolerance-Is it worth it?{"}",
author = "Finger, {Erik B} and Strom, {Terry B.} and Matas, {Arthur J}",
year = "2014",
month = "1",
day = "1",
doi = "10.1101/cshperspect.a015594",
language = "English (US)",
volume = "4",
journal = "Cold Spring Harbor perspectives in medicine",
issn = "2157-1422",
publisher = "Cold Spring Harbor Laboratory Press",
number = "2",

}

TY - JOUR

T1 - Tolerance-Is it worth it?

AU - Finger, Erik B

AU - Strom, Terry B.

AU - Matas, Arthur J

PY - 2014/1/1

Y1 - 2014/1/1

N2 - We are entering an exciting time in the study of immunologic tolerance. Several cellular and molecular strategies have been developed that show promise in nonhuman transplant models and these approaches are just now appearing in clinical trials. Tolerance strategies that prevent immune rejection and obviate the need for immunosuppressive medications (with inherent risk of cancer, infection, and organ toxicity) would improve both graft and patient survival. Each tolerance protocol brings its ownset of associated risks. As the results of these trials become available,we must continue to evaluate their successes and failures. The balance of these outcomes will help us answer the question: "Tolerance-Is it worth it?"

AB - We are entering an exciting time in the study of immunologic tolerance. Several cellular and molecular strategies have been developed that show promise in nonhuman transplant models and these approaches are just now appearing in clinical trials. Tolerance strategies that prevent immune rejection and obviate the need for immunosuppressive medications (with inherent risk of cancer, infection, and organ toxicity) would improve both graft and patient survival. Each tolerance protocol brings its ownset of associated risks. As the results of these trials become available,we must continue to evaluate their successes and failures. The balance of these outcomes will help us answer the question: "Tolerance-Is it worth it?"

UR - http://www.scopus.com/inward/record.url?scp=84893219031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893219031&partnerID=8YFLogxK

U2 - 10.1101/cshperspect.a015594

DO - 10.1101/cshperspect.a015594

M3 - Article

C2 - 24370928

AN - SCOPUS:84893219031

VL - 4

JO - Cold Spring Harbor perspectives in medicine

JF - Cold Spring Harbor perspectives in medicine

SN - 2157-1422

IS - 2

ER -